Bayer — Clinical Trial Pipeline

Bayer has 8 registered trials in the index.

Trials (8)

• A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors Phase 2 · Bayer
• Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer Phase 2 · Bayer
• Gadobutrol Magnevist-controlled Body Study Phase 3 · Bayer
• A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC) Phase 1/2 · Bayer
• How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany N/A · Bayer
• A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants Phase 1 · Bayer
• Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib N/A · Bayer
• First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib Phase 2 · Bayer

Related landscapes

• Solid Tumors Harboring NTRK Fusion
• Breast Neoplasms
• Magnetic Resonance Imaging
• Bone Metastases
• Castration-Resistant Prostate Cancer

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.